Navigation Links
Intellikine Completes $51 Million Financing
Date:7/8/2009

LA JOLLA, Calif., July 8 /PRNewswire/ -- Intellikine, Inc., a leader in the development of innovative, small molecule drugs for the treatment of cancer, inflammation and autoimmune diseases, announced today that it has raised $51 million in preferred stock financing. Novartis Bioventures Ltd. led the financing in which additional new investors U.S. Venture Partners, Biogen Idec and FinTech Global Capital participated. Markus Goebel, M.D., Ph.D., Managing Director of the Novartis Venture Funds, will join the company's board of directors.

The investment includes a $28.5 million first closing. In addition, the company can access up to another $22.5 million, subject to the performance of certain milestones, which, if triggered, will bring the total amount raised in this round to $51 million. This latest financing comes less than two years after the company was formed with an initial investment of $12.5 million from founding investors Abingworth, CMEA Capital and Sofinnova Ventures, all of whom participated in this latest financing.

Intellikine is developing a portfolio of isoform-selective inhibitors of the phosphatidyinositol-3-kinase (PI3K) pathway for the treatment of cancer, inflammation and autoimmune diseases. The company has discovered multiple classes of proprietary compounds that are potent, selective and druglike inhibitors of PI3K isoforms. The company's most advanced compound, INK128, a selective TORC1/2 inhibitor, has demonstrated efficacy in multiple models of cancer and is expected to enter Phase I clinical studies within twelve months.

"We are delighted to have generated such excitement among both new and existing investors," said Troy Wilson, Ph.D., J.D., President and Chief Executive Officer of Intellikine. "This financing gives us the resources necessary to advance our pipeline of PI3K/mTOR inhibitors into clinical development as well as significant flexibility to build strategic partner
'/>"/>

SOURCE Intellikine, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action
2. Verenium Completes Amendment to 8% Senior Convertible Notes
3. Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
4. Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial
5. Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait
6. EFT BioTech Holdings, Inc.s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait
7. Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma
8. Cordex Completes Production of ATPace(TM) Clinical Trial Material
9. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
10. Brooks Instrument Completes Acquisition of Celerity's Instrumentation Division
11. Sinovac Completes Construction of H1N1 Virus Seed Bank

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/5/2009)...TATION -- Gone hybrid . . . , Fuel economy rat...ow posted at the www.fueleconomy.gov web site, w...aintains for the U.S. Department of Energy and the... top 10 vehicles on the best fuel economy list are... city; 48 highway). "This list proves that hybrids...
(Date:11/5/2009)...CORDOVA, Calif., Nov. 5 ...pplier of innovative products for processing and s...r the first quarter of fiscal 2010. ,, For the ...rted revenues of $5.2 million, a 15 percent increa...ter a year ago. The Company said the key contribut...
(Date:11/5/2009)...RTH, Texas, Nov. 5 Wound...today that it has entered into a Letter of Intent ...al Health Technologies, Inc. (OTC Bulletin Board: ...0,000 in cash and debt, 4,000,000 shares of WNDM a...NDM on the Veriscrip technology being acquired fro...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...SWX:,ROG.VX; RO.S) announced today that it gave no...SI ), as required by Ventana,s bylaws, that it wil...na,s board of directors at,Ventana,s 2008 annual s...menced a tender offer to acquire all of the,outsta...e in cash. This,price represents a 44% premium to ...
...ty of,Hematology (ASH), the world,s largest profes...ore than 20,000 attendees at the 49th ASH Annual,M...d Congress Center in,Atlanta. The meeting will pre... disorders., "The ASH annual meeting is the premi...d the world to hear the most up-to-date developmen...
...roChem,s,(OTC Bulletin Board: MACM), (http://www...., will present at the upcoming Equities Magazine W... Club in New York City on December 7,2007. Mr. DeL...he Equities Corporate Conference is an all day eve...ublic company CEOs from a wide range of,sectors. T...
Other Biology Technology:Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 2Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 3Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 4Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 5Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 6Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 7Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 849th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 3MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York 2MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York 3
(Date:11/3/2009)... Samueli School of Engineering and Applied Science...d in the laboratory the enzyme responsible for pro...ovastatin. , The research, published Oct. 23 ...o the development of other compounds with similarl...sizing enzyme is one of the most interesting but l...
(Date:11/3/2009)...f Illinois at Chicago have received $1 million fro...study the relationship between "fat taxes" and foo...unding for the two-year project was made available...t of 2009. , The study will link state tax rates...ar- and fat-laden foods and beverages (soda, candy...
(Date:11/3/2009)...wswire/ -- EmSense Corporation, the company that c...ave measurement technology, today announced the co..., led by an investment from Technology Partners wi...ipating. ,, This funding will allow EmSense to ...ny market research partners. The funds will also ...
Breaking Biology News(10 mins):UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2EmSense Raises $9 Million Series C Round of Financing 2Memory test and PET scans detect early signs of Alzheimers 51577 1Memory test and PET scans detect early signs of Alzheimers 51577 2Memory test and PET scans detect early signs of Alzheimers 51577 3Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 1Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 2Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 3Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 4Simulating medical situations helps students learn retain basic science concepts 51568 1Simulating medical situations helps students learn retain basic science concepts 51568 2
...Put a mouse or a rat under stress and what does it...hen people suffer nontraumatic stress they often h...a pounds. , When Syrian hamsters, which are normal...n, they also gain weight. So scientists at the Cen...niversity are using hamsters as a model for human ...
...New technologies that mimic the way insects, plant...help reduce our dependence on energy, according to...al Interface. , When faced with engineering diffic...emes of heat, up to 70 per cent of man-made techno...unt used, in order to resolve the problem. , Howe...
...In the United States, Lyme disease incidence has s...rst year national statistics were collected) to a ...er zoonoses, is transmitted by a vector that picks...rate host. In the eastern and central United State...nfects blacklegged ticks, Ixodes scapularis, which...
Other Biology News:Just like us, social stress prompts hamsters to overeat, gain weight 2Just like us, social stress prompts hamsters to overeat, gain weight 3Just like us, social stress prompts hamsters to overeat, gain weight 4Copying nature could save us energy, study shows 2A new view on Lyme disease: Rodents hold the key to annual risk 2A new view on Lyme disease: Rodents hold the key to annual risk 3
Pectinase from Sigma-Aldrich
Rat Anti-STENOTROPHOMONAS MALTOPHILIA Polyclonal Antibody, Unconjugated from AbD Serotec
Workstation/Stacking System from ABgene
...nd is designed for paramagnetic bead precipitation...tand has a plastic base in a standard SBS 96 well ...y strong permanent magnetic rings enables fast and...d, paramagnetic beads in a U-bottom plate will pel...
Biology Products: